Dividend Assets Capital LLC lowered its position in shares of CVS Health Corporation (NYSE:CVS) by 9.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,050,072 shares of the pharmacy operator’s stock after selling 113,559 shares during the period. CVS Health Corporation makes up about 3.0% of Dividend Assets Capital LLC’s holdings, making the stock its 7th largest position. Dividend Assets Capital LLC owned about 0.10% of CVS Health Corporation worth $100,534,000 as of its most recent filing with the SEC.

Other hedge funds also recently added to or reduced their stakes in the company. Traynor Capital Management Inc. acquired a new stake in shares of CVS Health Corporation during the second quarter valued at $201,000. MU Investments Co. Ltd. increased its stake in shares of CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock valued at $109,000 after buying an additional 440 shares in the last quarter. Bartlett & Co. LLC increased its stake in shares of CVS Health Corporation by 0.8% in the second quarter. Bartlett & Co. LLC now owns 373,813 shares of the pharmacy operator’s stock valued at $35,789,000 after buying an additional 2,964 shares in the last quarter. Aviance Capital Management LLC increased its stake in shares of CVS Health Corporation by 10.7% in the second quarter. Aviance Capital Management LLC now owns 13,399 shares of the pharmacy operator’s stock valued at $1,283,000 after buying an additional 1,294 shares in the last quarter. Finally, Candriam Luxembourg S.C.A. increased its stake in shares of CVS Health Corporation by 14.4% in the second quarter. Candriam Luxembourg S.C.A. now owns 96,317 shares of the pharmacy operator’s stock valued at $9,222,000 after buying an additional 12,096 shares in the last quarter. Hedge funds and other institutional investors own 80.95% of the company’s stock.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) traded up 0.50% on Monday, hitting $86.83. The stock had a trading volume of 5,342,289 shares. The stock has a 50 day moving average price of $91.41 and a 200 day moving average price of $96.91. The company has a market cap of $92.58 billion, a P/E ratio of 19.97 and a beta of 0.83. CVS Health Corporation has a 1-year low of $85.89 and a 1-year high of $106.67.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.30 by $0.02. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. The company had revenue of $43.70 billion for the quarter, compared to the consensus estimate of $44.28 billion. During the same quarter in the previous year, the business earned $1.19 EPS. CVS Health Corporation’s revenue was up 17.6% compared to the same quarter last year. On average, equities research analysts expect that CVS Health Corporation will post $5.86 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 3rd. Investors of record on Monday, October 24th will be issued a dividend of $0.425 per share. The ex-dividend date is Thursday, October 20th. This represents a $1.70 dividend on an annualized basis and a yield of 1.96%. CVS Health Corporation’s dividend payout ratio is presently 39.08%.

CVS has been the subject of several recent analyst reports. Morgan Stanley downgraded CVS Health Corporation from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $111.00 to $104.00 in a research report on Monday, June 20th. Credit Suisse Group AG restated an “outperform” rating and set a $110.00 price objective (down from $115.00) on shares of CVS Health Corporation in a research report on Tuesday, October 4th. Robert W. Baird dropped their price objective on CVS Health Corporation from $114.00 to $104.00 and set an “outperform” rating for the company in a research report on Monday, October 3rd. Leerink Swann reaffirmed an “outperform” rating and issued a $105.00 target price (down previously from $110.00) on shares of CVS Health Corporation in a report on Sunday, October 2nd. Finally, Jefferies Group reaffirmed a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 4th. Five analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $112.40.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.